The effect of body mass index and oestrogen receptor level on survival of breast cancer patients
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: Epidemiological studies have demonstrated that obesity and low oestrogen receptor level adversely affect survival from breast cancer. Few studies have examined the joint effects of these variables. METHODS: A cohort study was conducted in which 1169 breast cancer patients from the Northern Alberta Breast Cancer Registry were followed for an average of 4.4 years. A number of variables related to breast cancer incidence and prognosis were studied. Body mass index (BMI) was used as a proxy measure of obesity. RESULTS: A Cox regression analysis resulted in a final model with terms for size of tumour, number of positive axillary nodes, oestrogen receptor level, BMI, and age at diagnosis, plus an interaction term for node status and BMI. Having relatively less oestrogen receptor increased the hazard ratio by 1.8 (95% CI: 1.4-2.3); for woman with no positive nodes, being in the highest quartile of BMI increased the hazard ratio by 2.5 (95% CI: 1.2-5.2) compared to the lowest quartile. CONCLUSIONS: BMI and oestrogen receptor level independently influence survival from breast cancer, but BMI affects survival only in patients with no positive axillary nodes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Physical activity and survival after breast cancer diagnosis
Holmes, M. D. (2005) · JAMA · doi:10.1001/jama.293.20.2479 · Cited by 1,772
Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu042 · Cited by 1,165
“[30,93,94,98,99,109-111] had an average follow-up of more than five years.”
BackgroundOrigins of socio-economic inequalities in cancer survival: a review
Woods, L. M., Rachet, B., & Coleman, M. P. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj007 · Cited by 1,106
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962
Weight, Weight Gain, and Survival After Breast Cancer Diagnosis
Kroenke, C. H., Chen, W. Y., Rosner, B., & Holmes, M. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.079 · Cited by 670
Weight Loss in Breast Cancer Patient Management
Chlebowski, R. T., Aiello, E. J., & McTiernan, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1128 · Cited by 623
Obesity, adipocytokines, and insulin resistance in breast cancer
Rose, D. P., Komninou, D., & Stephenson, G. D. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00142.x · Cited by 460
“Obesity is a risk factor for breast cancer in post-menopausal women (2–4), and obese women regardless of their menopausal status are particularly likely to have metastatic breast cancer when they are first diagnosed, and to have a poor final outcome (3,5,6).”
BackgroundSoy for Breast Cancer Survivors: A Critical Review of the Literature
Messina, M. J., & Loprinzi, C. L. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3095s · Cited by 359
Meyerhardt, J. A., Catalano, P. J., Haller, D. G., Mayer, R. J., Benson, A. B., Macdonald, J. S., & Fuchs, C. S. (2003) · Cancer · doi:10.1002/cncr.11544 · Cited by 306
Daling, J. R., Malone, K. E., Doody, D. R., Johnson, L. G., Gralow, J. R., & Porter, P. L. (2001) · Cancer · doi:10.1002/1097-0142(20010815)92:4<720::aid-cncr1375>3.0.co;2-t · Cited by 264
Thomson, C. A., Stopeck, A. T., Bea, J. W., Cussler, E., Nardi, E., Frey, G., & Thompson, P. A. (2010) · Nutrition and Cancer · doi:10.1080/01635581.2010.513803 · Cited by 94
Metadata
- Authors
- Newman, S., Lees, A., & Jenkins, H.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-06-01
- Volume
- 26
- Issue
- 3
- Pages
- 484-490
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2101350289
- Cited by
- 82
- References
- 0
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.